IDEXX Laboratories Inc.

02/17/2026 | Press release | Distributed by Public on 02/17/2026 18:31

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Underberg Sharon E.
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [IDXX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP, GC & Corporate Secretary
(Last) (First) (Middle)
ONE IDEXX DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026
(Street)
WESTBROOK, ME 04092
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/14/2026 M 173 A $ 0 6,532.654(1) D
Common Stock 02/14/2026 M 176 A $ 0 6,708.654 D
Common Stock 02/14/2026 M 218 A $ 0 6,926.654 D
Common Stock 02/14/2026 M 265 A $ 0 7,191.654 D
Common Stock 02/14/2026 F 251 D $629.35(2) 6,940.654 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy) $617.2 02/12/2026 A 3,738 (3) 02/11/2036 Common Stock 3,738 $ 0 3,738 D
Incentive Stock Option (right-to-buy) $617.2 02/12/2026 A 162 (4) 02/11/2036 Common Stock 162 $ 0 162 D
Restricted Stock Unit (5) 02/12/2026 A 891 (5) (5) Common Stock 891 $ 0 891 D
Restricted Stock Unit (6) 02/14/2026 M 173 (6) (6) Common Stock 173 $ 0 0 D
Restricted Stock Unit (7) 02/14/2026 M 176 (7) (7) Common Stock 176 $ 0 176 D
Restricted Stock Unit (8) 02/14/2026 M 218 (8) (8) Common Stock 218 $ 0 434 D
Restricted Stock Unit (9) 02/14/2026 M 265 (9) (9) Common Stock 265 $ 0 795 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Underberg Sharon E.
ONE IDEXX DRIVE
WESTBROOK, ME 04092
EVP, GC & Corporate Secretary

Signatures

/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg 02/17/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 333.654 shares held in the ESPP which has been increased by 0.001 shares due to a rounding calculation of previously issued fractional shares.
(2) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
(3) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
(4) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
(5) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027.
(6) Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.
(7) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
(8) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
(9) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
IDEXX Laboratories Inc. published this content on February 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 18, 2026 at 00:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]